Skip to content
DefDex

Federal award

QUIDELORTHO SALES COMPANY, LLC

HT940623F0025

Contract

Obligated and Ceiling

Obligated (net)
$2,065,772.34
Ceiling (potential value, not spending)
$3,079,185.09
Current value
$2,065,772.34
Gross positive obligations
$2,065,772.34

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
QUIDELORTHO SALES COMPANY, LLC · ZFXRG96JMJ39
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
QUIDELORTHO SALES COMPANY, LLC · ZFXRG96JMJ39
Awarding agency
Department of War · sub-agency 97DH · office HT9406
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
PIID
HT940623F0025
Parent vehicle (IDV PIID)
V797D60637
Award type code
C
Actions
10 · Mar 2, 2023 to Dec 17, 2025
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History10

Award actions
DateFYModAction typeObligationCompany in company totals
Dec 17, 2025FY2026P00009C$576,303.36
—
Dec 11, 2025FY2026P00008B$0.00
—
Oct 23, 2025FY2026P00007M$0.00
—
Sep 8, 2025FY2025P00006G$0.00
—
Nov 20, 2024FY2025P00005C$662,691.78
—
Sep 18, 2024FY2024P00004G$0.00
—
Oct 23, 2023FY2024P00003C$662,691.78
—
Sep 7, 2023FY2023P00002G$0.00
—
Aug 21, 2023FY2023P00001B$0.00
—
Mar 2, 2023FY20230—$164,085.42
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.